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“Women in their childbearing years account 
for the largest population of Americans 
with depression. Depression is one of 
the most common complications during 
pregnancy and the number one risk factor 
for postpartum depression. Approximately 
one in 10 women will have major or minor 
depression sometime during pregnancy and 
the postpartum period.” (ACOG, May 7, 
2007.)
During pregnancy and the postpartum period, two notably major life events for women, 
significant hormonal changes take 
place that increase vulnerability for 
depression. At the same time, many 
women during these periods find 
themselves in stressful situations exacerbated by the 
changes in life circumstances inherent with having 
children.  While the vast majority of women adjust 
successfully to pregnancy and motherhood, some 
portion of women find the everyday challenges 
exceedingly difficult to manage.  For these women 
the childbearing years can be the “perfect storm” 
for major depressive disorder (MDD).
Depression During Pregnancy and 
the Postpartum Period
Major depressive disorder, also known as major 
depression, clinical depression, or unipolar 
depression, is the most common neuropsychiatric 
disorder of adults. MDD affects more women 
than men, and is the third most prevalent cause 
of disability. (Blazer et al., 1994; Regier et al., 
1988.) Depression during pregnancy and/or the 
postpartum period occurs in approximately 10-
15% of women (Bennett, Einarson, Taddio, Koren, 
& Einarson, 2004; Deitz et al, 2007) while rates of 
postpartum depression have been reported as high 
as 25% (Gregiore et al., 1996).  
Women who experience depression during 
pregnancy and the postpartum period may 
experience a variety of symptoms which include, 
but are not limited to:
•	 Sadness
•	 Low self esteem
•	 Emptiness
•	 Exhaustion
•	 Hopelessness
•	 Social withdrawal
•	 Low or no energy
•	 Difficulty concentrating or making decisions
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Challenges of Diagnosing Perinatal 
and Postpartum Depression
Depression is one of the most common health 
obstacles during and after pregnancy.  The physical and 
emotional changes a woman experiences during these 
periods, such as fatigue, weight gain and insomnia, 
can resemble symptoms associated with depression. 
Consequently, depressive symptoms among pregnant 
women and new mothers are often overlooked, under 
diagnosed and under treated (ACOG).  Complicating 
matters further, depressed pregnant women often may 
not seek prenatal care (Marcus, 2009), which may result 
in further complications for both mother and infant 
(Andersson, Sundstrom-Poromaa, Wulff, Astrom, & 
Bixo, 2004; Chung, Lau, Yip, Chiu, & Lee, 2001; Grote 
et al., 2010.)  Finally, women with depressive symptoms 
during pregnancy are at a markedly increased risk for 
developing postpartum depression (Robertson, Grace, 
Wallington, & Stewart, 2004). Untreated postpartum 
depression can have lasting effects.  Women who 
have experienced postpartum depression can have 
significant difficulties bonding with their children, and 
are at increased risk for reoccurrence with subsequent 
pregnancies (ACOG).  
The good news is that depression is a treatable illness; 
however, the majority of women with a MDD diagnosis 
are either untreated or under-treated (Flynn, Blow, & 
Marcus, 2006). 
Treatment Considerations During 
Pregnancy
Research suggests that women experiencing depression 
during pregnancy can improve when treated with 
therapy and/or medication prior to delivery.   Relevant 
findings include:
•	 Women with mild to moderate depression
 may benefit from individual and group
psychotherapy including cognitive behavioral 
 or interpersonal therapy. (Spinelli & Endicott,
 2003.) 
•	 Antidepressant medication is often 
recommended in combination with psychotherapy 
for patients with moderate depressive symptoms. 
Patients with more severe depression may need to 
consider additional treatment options. (Yonkers 
et al., 2009) 
•	 Of women taking antidepressant medication
during pregnancy, two-thirds of these women 
may benefit from increases in medication 
particularly during mid to late pregnancy 
(Hostetter, Stowe, Strader, McLaughlin, 
& Llewellyn, 2000). Medication may need 
to be adjusted because of physiological, 
psychosocial, and metabolic changes 
associated with pregnancy.  (Sit, Perel, 
Helsel, & Wisner, 2008)
Many  women may be concerned that antidepressant 
medication may be harmful if taken during 
pregnancy, or that the baby may have symptoms 
from medication exposure after delivery.  While 
taking antidepressant medication during pregnancy 
may have harmful effects on infants, the risks to 
mother and baby from not receiving adequate 
treatment must be considered. 
Treatment Considerations During 
the Postpartum Period
During the postpartum period, individual 
psychotherapies including interpersonal 
psychotherapy and cognitive-behavioral therapy 
show positive results in reducing maternal 
depressive symptoms. Mother-infant-relationship-
based psychotherapies may also improve parenting 
and child outcomes. (Cicchetti, Rogosch, & Toth, 2000) 
•	 For women with moderate to severe   
 depression, antidepressant therapy has  
 shown to be an effective treatment.
•	 Women should be screened for the presence
of depressive symptoms in the postpartum 
period.
•	 Standardized assessments should be used to
 monitor symptoms and help guide treatment.
•	 For women who are breastfeeding their  
 infants, the health benefits associated with  
 breastfeeding must be thoughtfully 
considered together with the benefits of 
depression treatment and the potential risks 
associated with antidepressant exposure to 
the infant via breast milk. (Fortinguerra, 
Calvenna, & Bonati, 2009; Stuebe & 
Schwarz, 2010). 
This does not necessarily mean that breastfeeding 
and taking antidepressent medications are 
incompatible. For more detailed information about 
taking medication during pregnancy and while 
breastfeeding, a woman should talk with her doctor.
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